Industry News
Scientists challenge the genetic interpretation of biology
Feb 21, 2014
A proposal for reformulating the foundations of biology, based on the 2nd law of thermodynamics and which is in sharp contrast to the prevailing genetic view, is published in the Journal of the Royal Society Interface under the title "Genes without prominence: a reappraisal of the foundations of biology". Read More
Computer models created to explore the complex biochemical processes that drive cancer growth
Feb 21, 2014
Life can be messy at all scales, requiring different organizational strategies -- from cleaning the house, to removing damaged or expired cells from the body to avoid cancer progression.In a messy house, people use computers to manage paper and photo clutter; companies use computer systems to track their inventory. Now a team of researchers at Vanderbilt University in Nashville, Tenn. Read More
Advanced prostate cancer risk could be identified by genetic screening
Feb 21, 2014
New research from the Institute of Cancer Research in the UK suggests that screening men with a family history of prostate cancer for certain gene mutations could identify those who are at increased risk of aggressive forms of the disease and need lifelong monitoring. Read More
Added benefit of Afatinib depends on mutation status in non-small cell lung cancer
Feb 21, 2014
Lung cancer patients with Del19 mutation benefit mostAfatinib (trade name: GIOTRIF) has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI). Read More
Reduced risk of cervical lesions associated with HPV vaccination in Denmark
Feb 21, 2014
A reduced risk of cervical lesions among Danish girls and women at the population level is associated with use of a quadrivalent HPV vaccine after only six years, according to a new study published in the Journal of the National Cancer Institute.Two HPV vaccines are currently available and have proven to be highly effective against HPV16/18-associated cervical cancer. Read More
Genetically modified T cells induced complete remissions in 88 percent of advanced leukemia patients treated
Feb 21, 2014
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells. Read More
'Epidemic of diagnosis' associated with thyroid cancer
Feb 21, 2014
According to a new study published in JAMA Otolaryngology-Head & Neck Surgery, increased incidence of thyroid cancer may not be because of an increase in the disease, but an increase in diagnosis.Several types of cancer can affect the thyroid - a gland in the neck that produces hormones. Read More
Genetic screening could identify risk of advanced prostate cancer
Feb 21, 2014
New research from the Institute of Cancer Research in the UK suggests that screening men with a family history of prostate cancer for certain gene mutations could identify those who are at increased risk of aggressive forms of the disease and need lifelong monitoring. Read More
Gene test developed to accurately classify brain tumors
Feb 21, 2014
Scientists at The Wistar Institute have developed a mathematical method for classifying forms of glioblastoma, an aggressive and deadly type of brain cancer, through variations in the way these tumor cells "read" genes. Their system was capable of predicting the subclasses of glioblastoma tumors with 92 percent accuracy. Read More
Genetically modified T cells induced complete remissions in 88 percent of advanced leukemia patients treated
Feb 21, 2014
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells. Read More
Previous Page Next Page